Genprex, Inc.
(NASDAQ : GNPX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.60%123.280.7%$1936.14m
PFEPfizer Inc. -2.71%30.890.9%$1431.38m
MRKMerck & Co., Inc. -2.49%71.700.7%$1293.00m
ABBVAbbVie, Inc. -1.73%72.552.3%$1211.13m
BMYBristol-Myers Squibb Co. 1.07%52.811.0%$1063.11m
LLYEli Lilly & Co. -0.23%134.041.1%$895.93m
FTSVForty Seven, Inc. 0.09%94.550.0%$324.65m
NVSNovartis AG -0.51%79.330.2%$314.08m
GSKGlaxoSmithKline Plc -2.09%36.470.2%$276.86m
AZNAstraZeneca Plc 0.31%42.491.2%$268.45m
NVONovo Nordisk A/S 1.21%56.650.1%$166.60m
SNYSanofi -1.19%42.440.2%$158.34m
BHCBausch Health Cos., Inc. -6.28%14.470.0%$103.86m
RGENRepligen Corp. 1.25%92.557.1%$72.48m
RETAReata Pharmaceuticals, Inc. 0.73%149.993.4%$67.52m

Company Profile

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.